[1]应志敏,严世贵.阿司匹林预防全髋或全膝置换术后深静脉血栓形成的循证医学进展[J].中华老年骨科与康复电子杂志,2018,(02):111-117.[doi:10.3877/cma.j.issn.2096-0263.2018.02.009]
　Ying Zhimin,Yan Shigui.State-of-the-Art evidence-based review of aspirin for thromboprophylaxis in modern elective total hip and kneearthroplasty[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2018,(02):111-117.[doi:10.3877/cma.j.issn.2096-0263.2018.02.009]
点击复制

阿司匹林预防全髋或全膝置换术后深静脉血栓形成的循证医学进展()
分享到：

中华老年骨科与康复电子杂志[ISSN:1674-3911/CN:11-9292/R]

卷:
期数:
2018年02期
页码:
111-117
栏目:
综述
出版日期:
2018-03-31

文章信息/Info

Title:
State-of-the-Art evidence-based review of aspirin for thromboprophylaxis in modern elective total hip and kneearthroplasty
作者:
应志敏; 严世贵
310009 杭州，浙江大学医学院附属第二医院骨科
Author(s):
Ying Zhimin;  Yan Shigui
Department of Orthopaedics Surgery, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, China
关键词:
阿司匹林;  关节成形术; 置换; 髋;  关节成形术; 置换; 膝;  静脉血栓形成
Keywords:
Aspirin;  Arhtroplasty;  replacement;  hip;  Arthroplasty;  replacement;  knee;  Venous thromboembolism
DOI:
10.3877/cma.j.issn.2096-0263.2018.02.009
文献标志码:
A
摘要:
目的 探讨阿司匹林预防全髋置换术（THA）或全膝置换术（TKA）后深静脉血栓形成（DVT）的循证医学研究证据。方法 检索英国国家医疗服务体系（National Health Service，NHS）数据库、研究转化临床实践（Turning Research into practice，TRIP）医学数据库、系统性评价Cochrane 数据库、OVID、Web of science、MEDLINE以及EMBASE数据库2004年1月至2017年9月发表的关于阿司匹林预防THA或TKA术后DVT的随机对照研究（RCT）文章，评价临床疗效主要转归结果是任何形式的DVT，次要转归结果是伤口并发症（伤口延迟渗出、感染）。结果 共纳入14篇文章，其中5篇I级研究证据的文章，9篇Ⅲ级研究证据；证据级别高的1篇RCT文章研究结果显示：阿司匹林与低分子肝素相比，TKA术后DVT发生率差异无统计学意义；目前支持阿司匹林相较低分子肝素、华法林或者达比加群酯对THA或TKA术后DVT预防效果要差的证据尚不充分；与阿司匹林相比，利伐沙班可以使得TKA或THA术后的无症状DVT发生率下降，但是否能够预防有症状的DVT，目前证据尚且不足；与阿司匹林相比，THA或TKA术后使用达比加群酯和利伐沙班伤口并发症要更高。结论 目前临床研究证据表明，除了当前的利伐沙班及低分子肝素抗凝药物外，阿司匹林也许能成为THA或TKA术后DVT预防的另一选择。
Abstract:
Objective There is uncertainty regarding the optimal means of thromboprophylaxis following total hip and knee arthroplasty (THA, TKA). This systematic evidence-based review presents the evidence for acetylsalicylic acid (aspirin) as a thromboprophylactic agent in THA and TKA and compares it with other chemoprophylactic agents. Methods A search of literature published between January 2004 and September 2017 was performed in the database including NHS、TRIP、Cochrane, MEDLINE and EMBASE in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Results A total of 14 studies were eligible for inclusion including 5 level I evidence studies and 9 level Ⅲ evidence studies; Evidence from one good quality randomized controlled trial (RCT) showed no difference in rates of venous thrombo-embolism (VTE) in patients given aspirin or low molecular weight heparin (LMWH) following TKA. There was insufficient evidence from trials with moderate to severe risk of bias being present to suggest aspirin is more or less effective than LMWH, warfarin or dabigatran for the prevention of VTE in TKA or THA. Compared with aspirin, rates of asymptomatic deep vein thrombosis (DVT) in TKA may be reduced with rivaroxaban but insufficient evidence exists to demonstrate an effect on incidence of symptomatic DVT. Compared with aspirin there is evidence of more wound complications following THA and TKA with dabigatran and in TKA with rivaroxaban. Conclusions The results suggest aspirin may be a suitable alternative to other thrombo prophylactic agents following THA and TKA. Further investigation is required to fully evaluate the safety and efficacy of aspirin.

参考文献/References:

1 Jacobs JJ, Mont MA, Bozic KJ, et al. American academy of orthopaedic surgeons clinical practice guideline on: preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty [J]. J Bone Joint Surg Am, 2012, 94(8): 746-747.
2 Harris WH, Salzman EW, Athanasoulis CA, et al. Aspirin prophylaxis of venous thromboembolism after total hip replacement [J]. N Engl J Med, 1977, 297(23): 1246-1249.
3 Harris WH, Athanasoulis CA, Waltman AC, et al. Prophylaxis of deep-vein thrombosis after total hip replacement. Dextran and external pneumatic compression compared with 1.2 or 0.3 gram of aspirin daily [J]. J Bone Joint Surg Am, 1985, 67(1): 57-62.
4 Bala A, Huddleston JI, Goodman SB, et al. Venous thromboembolism prophylaxis after TKA: aspirin, warfarin, enoxaparin, or factor Xa inhibitors? [J]. Clin Orthop Relat Res, 2017, 475(9): 2205-2213.
5 Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy [J]. Chest, 2004, 126(3 Suppl): 338S-400S.
6 Callaghan JJ, Dorr LD, Engh GA, et al. Prophylaxis for thromboembolic disease - Recommendations from the American College of Chest Physicians - Are they appropriate for orthopaedic surgery? [J]. J Arthroplasty, 2005, 20(3): 273-274.
7 Falck-Ytter Y, Francis CW, Johanson NA, et al. Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines [J]. Chest, 2012, 141(2 Suppl): e278S-e325S.
8 Jameson SS, Baker PN, Deehan DJ, et al. Evidence-base for aspirin as venous thromboembolic prophylaxis following joint replacement [J]. Bone Joint Res, 2014, 3(5): 146-149.
9 Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration [J]. PLoS Med, 2009, 6(7): e1000100.
10 OCEBM Levels of Evidence Working Group. The 2011 Oxford Centre for Evidenced-Based Medicine (OCEBM) Levels of Evidence. http://www.cebm.net/ocebmlevels-of-evidence/
11 Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of InterventionsVersion 5. 1.0. [updated March 2011]. The Cochrane Collaboration, 2011, http://handbook.cochrane.org/
12 Sterne JAC, Higgins JPT, Reeves BC, on behalf of the development group for ACROBAT-NRSI. A Cochrane Risk Of Bias Assessment Tool: for Non-RandomizedStudies of Interventions (ACROBAT-NSRI), Version 1.0.0, 2014, http://www.riskofbias.info
13 Anderson DR, Dunbar MJ, Bohm ER, et al. Aspirin versus low-molecular-weight heparin for extended venous thromboembolism prophylaxis after total hip arthroplasty: a randomized trial [J]. Ann Intern Med, 2013, 158(11): 800-806.
14 Gelfer Y, Tavor H, Oron A, et al. Deep vein thrombosis prevention in joint arthroplasties - Continuous enhanced circulation therapy vs low molecular weight heparin [J]. J Arthroplasty, 2006, 21(2): 206-214.
15 Kulshrestha V, Kumar S. DVT prophylaxis after TKA: routine anticoagulation vs risk screening approach - a randomized study [J]. J Arthroplasty, 2013, 28(10): 1868-1873.
16 Gill SK, Theodorides A, Smith N, et al. Wound problems following hip arthroplasty before and after the introduction of a direct thrombin inhibitor for thromboprophylaxis [J]. Hip Int, 2011, 21(6): 678-683.
17 Beksaç B, González Della Valle A, Anderson J, et al. Symptomatic thromboembolism after one-stage bilateral THA with a multimodal prophylaxis protocol [J]. Clin Orthop Relat Res, 2007, 463: 114-119.
18 Westrich GH, Bottner F, Windsor RE, et al. VenaFlow plus Lovenox vs VenaFlow plus aspirin for thromboembolic disease prophylaxis in total knee arthroplasty [J]. J Arthroplasty, 2006, 21(6 Suppl 2): 139-143.
19 Zou Y, Tian S, Wang Y, et al. Administering aspirin, rivaroxaban and low-molecular-weight heparin to prevent deep venous thrombosis after total knee arthroplasty [J]. Blood Coagul Fibrinolysis, 2014, 25(7): 660-664.
20 Sehat KR, Evans R, Newman JH. How much blood is really lost in total knee arthroplasty? - Correct blood loss management should take hidden loss into account [J]. Knee, 2000, 7(3): 151-155.
21 Jiang Y, Du H, Liu J, et al. Aspirin combined with mechanical measures to prevent venous thromboembolism after total knee arthroplasty: a randomized controlled trial [J]. Chin Med J (Engl), 2014, 127(12): 2201-2205.
22 Intermountain Joint Replacement Center Writing Committee. A prospective comparison of warfarin to aspirin for thromboprophylaxis in total hip and total knee arthroplasty [J]. J Arthroplasty, 2012, 27(1): 1-9.e2.
23 Cafri G, Paxton EW, Chen Y, et al. Comparative effectiveness and safety of drug prophylaxis for prevention of venous thromboembolism after total knee arthroplasty [J]. J Arthroplasty, 2017, 32(11): 3524-3528.e1.
24 Bloch BV, Patel V, Best AJ. Thromboprophylaxis with dabigatran leads to an increased incidence of wound leakage and an increased length of stay after total joint replacement [J]. Bone Joint J, 2014, 96B(1): 122-126.
25 Hamilton SC, Whang WW, Anderson BJ, et al. Inpatient enoxaparin and outpatient aspirin chemoprophylaxis regimen after primary hip and knee arthroplasty: a preliminary study [J]. J Arthroplasty, 2012, 27(9): 1594-1598.
26 Gillette BP, Desimone LJ, Trousdale RT, et al. Low risk of thromboembolic complications with tranexamic acid after primary total hip and knee arthroplasty [J]. Clin Orthop Relat Res, 2013, 471(1): 150-154.
27 Chen MS, Lincoff AM. Direct thrombin inhibitors [J]. Curr Cardiol Rep, 2005, 7(4): 255-259.
28 Jameson SS, Charman SC, Gregg PJ, et al. The effect of aspirin and low-molecular-weight heparin on venous thromboembolism after hip replacement a non-randomised comparison from information in the national joint registry [J]. J Bone Joint Surg Br, 2011, 93B(11): 1465-1470.
29 Jameson SS, Baker PN, Charman SC, et al. The effect of aspirin and low-molecular-weight heparin on venous thromboembolism after knee replacement: a non-randomised comparison using National Joint Registry Data [J]. J Bone Joint Surg Br, 2012, 94(7): 914-918.
30 Khatod M, Inacio MC, Bini SA, et al. Pulmonary embolism prophylaxis in more than 30,000 total knee arthroplasty patients: is there a best choice? [J]. J Arthroplasty, 2012, 27(2): 167-172.
31 Bozic KJ, Vail TP, Pekow PS, et al. Does aspirin have a role in venous thromboembolism prophylaxis in total knee arthroplasty patients? [J]. J Arthroplasty, 2010, 25(7): 1053-1060.
32 Poultsides LA, Gonzalez Della Valle A, Memtsoudis SG, et al. Meta-analysis of cause of death following total joint replacement using different thromboprophylaxis regimens [J]. J Bone Joint Surg Br, 2012, 94(1): 113-121. 33 Cusick LA, Beverland DE. The incidence of fatal pulmonary embolism after primary hip and knee replacement in a consecutive series of 4253 patients [J]. J Bone Joint Surg Br,
2009, 91(5): 645-648.
34 Howie C, Hughes H, Watts AC. Venous thromboembolism associated with hip and knee replacement over a ten-year period: a population-based study [J]. J Bone Joint Surg Br, 2005, 87(12): 1675-1680.
35 Pedersen AB, Mehnert F, Sorensen HT, et al. The risk of venous thromboembolism, myocardial infarction, stroke, major bleeding and death in patients undergoing total hip and knee replacement: a 15-year retrospective cohort study of routine clinical practice [J]. Bone Joint J, 2014, 96-B(4): 479-485. 36 Antithrombotic Trialists’ Collaboration. Collaborative meta-analysis of randomised trials of anti
platelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients [J]. BMJ, 2002, 324(7329): 71-86.
37 Lussana F, Squizzato A, Permunian ET, et al. A systematic review on the effect of aspirin in the prevention of post-operative arterial thrombosis in patients undergoing total hip and total knee arthroplasty [J]. Thromb Res, 2014, 134(3): 599-603.
38 Parvizi J, Jacovides CL, Bican O, et al. Is deep vein thrombosis a good proxy for pulmonary embolus? [J]. J Arthroplasty, 2010, 25(6 Suppl): 138-144.
39 Eikelboom JW, Quinlan DJ, Douketis JD. Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials [J]. Lancet, 2001, 358(9275): 9-15.
40 Della Valle CJ, Steiger DJ, Dicesare PE. Duplex ultrasonography in patients suspected of postoperative pulmonary embolism following total joint arthroplasty [J]. Am J Orthop (Belle Mead NJ), 2003, 32(8): 386-388.
41 Cordoba G, Schwartz L, Woloshin S, et al. Definition, reporting, and interpretation of composite outcomes in clinical trials: systematic review [J]. Br Med J, 2010, 341: 3920.
42 Patel VP, Walsh M, Sehgal B, et al. Factors associated with prolonged wound drainage after primary total hip and knee arthroplasty [J]. Journal of Bone and Joint Surgery-American Volume, 2007, 89A(1): 33-38.
43 Jaberi MF, Eslampour A, Haytmanek CT, et al. Persistent surgical wound drainage after total hip and knee arthroplasty-risk factors and final outcome [J]. J Bone Joint Surg Br, 2009, 91-B(Suppl II): 298.
44 Carrothers AD, Rodriguez-Elizalde SR, Rogers BA, et al. Patient-reported compliance with thromboprophylaxis using an oral factor Xa inhibitor (rivaroxaban) following total hip and total knee arthroplasty [J]. J Arthroplasty, 2014, 29(7): 1463-1467.
45 Rogers BA, Phillips S, Foote J, et al. Is there adequate provision of venous thromboembolism prophylaxis following hip arthroplasty? An audit and international survey [J]. Ann R Coll Surg Engl, 2010, 92(8): 668-672.
46 Schousboe JT, Brown GA. Cost-effectiveness of low-molecular-weight heparin compared with aspirin for prophylaxis against venous thromboembolism after total joint arthroplasty [J]. J Bone Joint Surg Am, 2013, 95(14): 1256-1264.
47 Parvizi J, Huang R, Restrepo C, et al. Low-Dose aspirin is effective chemoprophylaxis against clinically important venous thromboembolism following total joint arthroplasty: a preliminary analysis [J]. J Bone Joint Surg Am, 2017, 99(2): 91-98.
48 Deirmengian GK, Heller S, Smith EB, et al. Aspirin can be used as prophylaxis for prevention of venous thromboembolism after revision hip and knee arthroplasty [J]. J Arthroplasty, 2016, 31(10): 2237-2240.
49 Ogonda L, Hill J, Doran E, et al. Aspirin for thromboprophylaxis after primary lower limb arthroplasty: early thromboembolic events and 90 day mortality in 11,459 patients [J]. Bone Joint J, 2016, 98-B(3): 341-348.

相似文献/References:

[1]徐明 付志厚 孙海宁 曲新涛 于秀淳.腓骨近端截骨与单髁关节置换治疗膝关节内侧单间室骨关节炎的疗效比较[J].中华老年骨科与康复电子杂志,2016,(01):26.[doi:10.3877/cma.j.issn.2096-0263.2016.01.006]
　Xu Ming,Fu Zhihou,Sun Haining,et al.Comparison study of proximal fibular osteotomy versus unicompartmental knee arthroplasty for medialcompartment osteoarthritis of the knee[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2016,(02):26.[doi:10.3877/cma.j.issn.2096-0263.2016.01.006]
[2]杨朝君 孙智文 田洪涛.腓骨近端截骨术与人工全膝关节置换术治疗内翻型膝关节骨关节炎的短期疗效比较[J].中华老年骨科与康复电子杂志,2016,(01):38.[doi:10.3877/cma.j.issn.2096-0263.2016.01.008]
　Yang Zhaojun,Sun Zhiwen,Tian Hongtao.Comparison on the short term treatment of varus knee osteoarthritis by proximal fibular osteotomy versus total knee arthroplasty[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2016,(02):38.[doi:10.3877/cma.j.issn.2096-0263.2016.01.008]
[3]李雪靖,张雪松,刘思思,等.腓骨近端截骨联合关节镜下清理治疗内翻型膝关节骨关节炎的成本效果分析[J].中华老年骨科与康复电子杂志,2016,(04):222.[doi:10.3877/cma.j.issn.2096-0263.2016.04.006]
　Li Xuejing,Zhang Xuesong,Liu Sisi,et al.Cost-effectiveness analysis of proximal fibular osteotomy combined with arthroscopy debridement for medial compartment knee ostoarthritis[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2016,(02):222.[doi:10.3877/cma.j.issn.2096-0263.2016.04.006]
[4]张静,李志锐,唐佩福.老年粗隆间骨折的手术治疗进展[J].中华老年骨科与康复电子杂志,2016,(04):250.[doi:10.3877/cma.j.issn.2096-0263.2016.04.011]
　Li Zhirui,Zhang Jing,Tang Peifu.Progress of surgical treatment for femoral intertrochanteric fracture in the elderly patients[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2016,(02):250.[doi:10.3877/cma.j.issn.2096-0263.2016.04.011]
[5]李涛,王英振,李玉龙,等.骨水泥与非骨水泥半髋关节置换治疗老年股骨颈骨折安全性的 Meta分析[J].中华老年骨科与康复电子杂志,2017,(02):109.[doi:10.3877/cma.j.issn.2096-0263.2017.02.008]
　Li Tao,Wang Yingzhen,Li Yulong,et al.Safety of cement and cementless hemiarthroplasty for femoral neck fractures in elderly patients: a meta- analysis[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2017,(02):109.[doi:10.3877/cma.j.issn.2096-0263.2017.02.008]
[6]陈佳,李西成.髋部骨折：争议与挑战[J].中华老年骨科与康复电子杂志,2017,(04):193.[doi:10.3877/cma.j.issn.2096-0263.2017.04.001]
　Chen Jia,Li Xicheng.Hip fracture: Controversy and challenge[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2017,(02):193.[doi:10.3877/cma.j.issn.2096-0263.2017.04.001]
[7]贾建波,禹宝庆,吴良浩,等.传统后路与微创 SuperPath入路的半髋置换治疗老年股骨颈骨折疗效比较[J].中华老年骨科与康复电子杂志,2017,(04):223.[doi:10.3877/cma.j.issn.2096-0263.2017.04.006]
　Jia Jianbo,Yu Baoqing,Wu Lianghao,et al.Hip hemiarthroplasty for senile femoral neck fractures: minimally invasive SuperPath approach versus traditional posterior approach[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2017,(02):223.[doi:10.3877/cma.j.issn.2096-0263.2017.04.006]
[8]扈鑫,高石军,董江涛,等.中老年全膝关节置换术后下肢深静脉血栓形成的解剖部位分布特点[J].中华老年骨科与康复电子杂志,2017,(05):296.[doi:10.3877/cma.j.issn.2096-0263.2017.05.009]
　Hu Xin,Gao Shijun,Dong Jiangtao,et al.The anatomical distribution of lower extremity deep vein thrombosis of middle-aged, and older patients after total knee arthroplasty[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2017,(02):296.[doi:10.3877/cma.j.issn.2096-0263.2017.05.009]
[9]姚尧,乔梁,王业贤,等.床旁超声在股骨颈骨折患者围手术期下肢深静脉血栓筛查中的作用[J].中华老年骨科与康复电子杂志,2018,(02):70.[doi:10.3877/cma.j.issn.2096-0263.2018.02.002]
　Yao Yao,Qiao Liang,Wang Yexian,et al.The clinical value of bedside ultrasound in the screening of perioperative lower extremity deep vein thrombosis in elderly patients with femoral neck fracture[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2018,(02):70.[doi:10.3877/cma.j.issn.2096-0263.2018.02.002]
[10]楚翔宇,程文俊,王俊文,等.老年股骨颈骨折全髋关节置换术围手术期下肢深静脉血栓形成的特点[J].中华老年骨科与康复电子杂志,2018,(02):75.[doi:10.3877/cma.j.issn.2096-0263.2018.02.003]
　Chu Xiangyu,Cheng Wenjun,Wang Junwen,et al.Features of deep venous thrombosis in aged patients with femoral neck fracture during the perioperative period[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2018,(02):75.[doi:10.3877/cma.j.issn.2096-0263.2018.02.003]

备注/Memo

备注/Memo:
基金项目：浙江省中医药科学研究基金项目（2018ZA072）
更新日期/Last Update: 2018-03-27